We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CYDY CytoDyn Inc (QB)

0.039 (22.81%)
Dec 01 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 2,387,228
Bid Price 0.208
Ask Price 0.2169
News -
Day High 0.2175


52 Week Range


Day Low 0.1651
Company Name Stock Ticker Symbol Market Type
CytoDyn Inc (QB) CYDY OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.039 22.81% 0.21 16:01:04
Open Price Low Price High Price Close Price Prev Close
0.18 0.1651 0.2175 0.21 0.171
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
306 2,387,228 $ 0.181591 $ 433,498 - 0.1456 - 0.48
Last Trade Time Type Quantity Stock Price Currency
16:00:51 formt 119,047 $ 0.21 USD

CytoDyn Inc (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
195.54M 921.12M 556.02M 0 -79.82M -0.09 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

CytoDyn (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No CYDY Message Board. Create One! See More Posts on CYDY Message Board See More Message Board Posts

Historical CYDY Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.1840.21750.150.16493653,686,2240.02614.13%
1 Month0.1550.21750.150.16676231,816,8850.05535.48%
3 Months0.2150.235040.14560.1717321,266,050-0.005-2.33%
6 Months0.26170.31030.14560.20717451,461,908-0.0517-19.76%
1 Year0.360.480.14560.25221851,650,962-0.15-41.67%
3 Years2.687.700.14561.752,485,645-2.47-92.16%
5 Years0.5810.010.05522.322,680,098-0.37-63.79%

CytoDyn (QB) Description

CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that is believed to play a role in numerous disease processes. CytoDyn is studying leronlimab in multiple therapeutic areas, including infectious disease, cancer, and autoimmune conditions.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |